RVLV:NYSERevolve Group, Inc. Analysis
Data as of 2026-06-12 - not real-time
$20.44
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Revolve Group delivered a strong first‑quarter performance, posting revenue of $342.9 million—a 15.6% year‑over‑year increase—and GAAP earnings of $0.20 per share, beating consensus estimates by 7.1%. Operating cash flow of $63.7 million and a cash balance exceeding $335 million underscore a solid liquidity position, while total debt remains modest at roughly $33 million. The company’s gross margin sits near 54%, with operating margins improving to around 4.6%, indicating effective cost management as it scales. However, the stock is trading at $20.44, below its 20‑day (19.35), 50‑day (22.17) and 200‑day (24.14) simple moving averages, signaling a short‑term bearish bias. Technical indicators show a bullish MACD histogram despite the overall bearish trend, and the price is hovering just above a key support level of $17.66 with resistance near $21.29.
Valuation metrics present a mixed picture: the discounted cash‑flow fair value of roughly $19.70 is slightly lower than the current price, yet analysts’ target median of $28 suggests a potential upside of over 30%. The forward PE of 19x and a price‑to‑book of 2.8 are reasonable for a growth‑oriented consumer‑cyclical player, but the stock’s beta of 1.48 and 30‑day volatility near 69% highlight heightened market risk. With the Fear & Greed Index in “Extreme Greed” territory, investor sentiment is overly bullish, which could amplify price swings. Overall, the fundamentals are strong, but the technical environment remains cautious.
Valuation metrics present a mixed picture: the discounted cash‑flow fair value of roughly $19.70 is slightly lower than the current price, yet analysts’ target median of $28 suggests a potential upside of over 30%. The forward PE of 19x and a price‑to‑book of 2.8 are reasonable for a growth‑oriented consumer‑cyclical player, but the stock’s beta of 1.48 and 30‑day volatility near 69% highlight heightened market risk. With the Fear & Greed Index in “Extreme Greed” territory, investor sentiment is overly bullish, which could amplify price swings. Overall, the fundamentals are strong, but the technical environment remains cautious.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish SMA alignment
- High short‑term volatility and elevated beta
- Stable trading volume supporting liquidity
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 15.6% YoY revenue growth and margin expansion
- Strong cash position and low debt enhancing financial flexibility
- Analyst consensus of “Buy” with a median target of $28
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Targeting Millennial and Gen Z consumers with a differentiated digital‑first model
- Planned store expansion and AI‑driven personalization to drive future growth
- Potential for sustained earnings improvement as margins stabilize
Key Metrics & Analysis
Financial Health
Revenue Growth15.60%
Profit Margin5.05%
P/E Ratio22.7
ROE12.94%
ROA6.48%
Debt/Equity6.33
P/B Ratio2.8
Op. Cash Flow$63.7M
Free Cash Flow$44.4M
Technical Analysis
TrendBearish
RSI51.0
Support$17.66
Resistance$21.29
MA 20$19.35
MA 50$22.17
MA 200$24.14
MACDBullish
VolumeStable
Fear & Greed Index88.07
Valuation
Fair Value$19.70
Target Price$29.69
Upside/Downside45.27%
GradeFair
TypeGrowth
Risk Assessment
Beta1.48
Volatility68.69%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.